Clinical Trial

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics of GenSci161 in Healthy Adult Participants

Name: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics of GenSci161 in Healthy Adult Participants — clinical trial record (NCT07476586)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

To Evaluate the Safety and Tolerability, Pharmacokinetics and Biomarker of GenSci161 in a Randomized, Double-blind, Placebo-controlled Study in Healthy Adult Participants.

Protocol Amendment History 1 change

critical Recruitment opened 2026-05-02

Trial Details

NCT Number	NCT07476586
Lead Sponsor	Changchun GeneScience Pharmaceutical Co., Ltd.
Conditions	Healthy Volunteers
Enrollment	44 participants
Start Date	2026-04-20
Primary Completion	2027-05-06 (estimated)
Study Completion	2027-08-10 (estimated)
Updated on ClinicalTrials.gov	2026-05-01